Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Kieburtz

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Discovering neuroprotection in Parkinson's disease, or getting to haphazardKarl Kieburtz
The Lancet. Neurology|March 26, 2016
Treating neurodegenerative disease before illness: a challenge for the 21st centuryKarl Kieburtz
Annals of Neurology|April 1, 2003
Designing neuroprotection trials in Parkinson's diseaseKarl Kieburtz
Journal of Neurology|November 19, 2008
Therapeutic strategies to prevent motor complications in Parkinson's diseaseKarl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2010
Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trialKarl Kieburtz,
The Lancet. Neurology|November 14, 2009
ADAGIO misses a beat?Karl Kieburtz
Neurology|May 24, 2006
Issues in neuroprotection clinical trials in Parkinson's diseaseKarl Kieburtz
Neurology|November 27, 2002
Needed in MS: evidence, not EVIDENCEKarl Kieburtz, Michael McDermott
Handbook of Clinical Neurology|February 21, 2023
Adaptive clinical trials and master protocolsAndrew McGarry, Karl Kieburtz
Neurology|June 30, 2005
Welding and Parkinson disease: is there a bond?Karl Kieburtz, Roger Kurlan
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Discovering neuroprotection in Parkinson's disease, or getting to haphazardKarl Kieburtz
The Lancet. Neurology|March 26, 2016
Treating neurodegenerative disease before illness: a challenge for the 21st centuryKarl Kieburtz
Annals of Neurology|April 1, 2003
Designing neuroprotection trials in Parkinson's diseaseKarl Kieburtz
Journal of Neurology|November 19, 2008
Therapeutic strategies to prevent motor complications in Parkinson's diseaseKarl Kieburtz
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2010
Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trialKarl Kieburtz,
The Lancet. Neurology|November 14, 2009
ADAGIO misses a beat?Karl Kieburtz
Neurology|May 24, 2006
Issues in neuroprotection clinical trials in Parkinson's diseaseKarl Kieburtz
Neurology|November 27, 2002
Needed in MS: evidence, not EVIDENCEKarl Kieburtz, Michael McDermott
Handbook of Clinical Neurology|February 21, 2023
Adaptive clinical trials and master protocolsAndrew McGarry, Karl Kieburtz
Neurology|June 30, 2005
Welding and Parkinson disease: is there a bond?Karl Kieburtz, Roger Kurlan
Pageof 19